Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03366792 · ClinicalTrials.gov registry record · NA
Comparative Analysis of Transperineal Versus Transrectal Approaches for MRI-Targeted Biopsy of the Prostate for the Detection and Characterization of Prostate Cancer
A NA study, sponsored by NYU Langone Health.
- Terminated
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT03366792 is a NA study that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 46 participants.
The verdict
NCT03366792, a NA study, was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate a transperineal biopsy approach (outside of the rectum) using MRI targeting to facilitate better access to the whole prostate gland and provide limited risk of infectious complications after biopsy.
Interventions
- DEVICE Artemis™ software system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2017-10-17 |
| Est. Completion | 2021-02-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03366792
The ClinicalTrials.gov registry entry for NCT03366792 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Artemis™ software system is the first listed.
NCT03366792 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03366792 about?
NCT03366792 is a clinical study titled "Comparative Analysis of Transperineal Versus Transrectal Approaches for MRI-Targeted Biopsy of the Prostate for the Detection and Characterization of Prostate Cancer". The purpose of this study is to investigate a transperineal biopsy approach (outside of the rectum) using MRI targeting to facilitate better access to the whole prostate gland and provide limited risk of infectious complications after biopsy.
What is the current status of trial NCT03366792?
This trial is currently terminated. It is a NA study. The enrollment target is 46 participants. The study started on 2017-10-17. Estimated completion is 2021-02-26.
What interventions are being tested in trial NCT03366792?
The interventions under investigation include: Artemis™ software system (DEVICE).
Who is sponsoring clinical trial NCT03366792?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.